Health
Life-extending drug for incurable breast cancer approved for NHS use – The Guardian
About 3,300 women a year may benefit from decision to approve ribociclib
Breast cancerAbout 3,300 women a year may benefit from decision to approve ribociclib
Fri 26 Feb 2021 08.57 EST
Women with incurable advanced breast cancer will be able to get a drug from the NHS that can potentially extend their life by almost eight months, under new guidance.
The National Institute for Health and Care Excellence (Nice) has approved the drug ribociclib , also known as Kisqali for routine use by the NHS in England and Wales. It said around 3,300 women a year with advanced breast…
-
Business16 hours agoThe smartest ASX dividend stocks to buy with $5,000 right now
-
Noosa News17 hours agoUniversity of Queensland researchers survey population of endangered White’s Seahorse
-
General16 hours agoMontana’s house was gutted by an accidental fire. Then her landlord accused her of starting it
-
Business14 hours ago2 must-have ASX shares to buy for dividend income investors